Annual Income Statements for RenaissanceRe
This table shows RenaissanceRe's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for RenaissanceRe
This table shows RenaissanceRe's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
1,577 |
365 |
495 |
1,174 |
-199 |
161 |
827 |
908 |
752 |
285 |
654 |
| Consolidated Net Income / (Loss) |
|
1,989 |
618 |
729 |
1,633 |
-19 |
-25 |
1,164 |
1,332 |
1,148 |
516 |
978 |
| Net Income / (Loss) Continuing Operations |
|
1,989 |
618 |
729 |
1,633 |
-19 |
-25 |
1,164 |
1,332 |
1,148 |
516 |
978 |
| Total Pre-Tax Income |
|
1,434 |
634 |
708 |
1,735 |
-83 |
-71 |
1,341 |
1,481 |
1,264 |
549 |
1,118 |
| Total Revenue |
|
3,179 |
2,576 |
2,805 |
3,950 |
2,223 |
3,443 |
3,175 |
3,168 |
2,941 |
2,163 |
2,737 |
| Net Interest Income / (Expense) |
|
-61 |
-23 |
-24 |
-24 |
-71 |
-27 |
-32 |
-31 |
-31 |
-32 |
-32 |
| Total Interest Income |
|
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
| Total Interest Expense |
|
61 |
23 |
24 |
24 |
71 |
27 |
32 |
31 |
31 |
32 |
32 |
| Long-Term Debt Interest Expense |
|
- |
23 |
24 |
24 |
- |
27 |
32 |
31 |
31 |
32 |
32 |
| Total Non-Interest Income |
|
3,240 |
2,599 |
2,829 |
3,974 |
2,293 |
3,470 |
3,207 |
3,198 |
2,973 |
2,195 |
2,769 |
| Other Service Charges |
|
0.14 |
-0.05 |
0.17 |
0.68 |
1.13 |
0.91 |
2.62 |
0.71 |
0.08 |
1.25 |
4.48 |
| Net Realized & Unrealized Capital Gains on Investments |
|
991 |
156 |
287 |
1,390 |
-235 |
749 |
792 |
764 |
638 |
10 |
565 |
| Premiums Earned |
|
2,249 |
2,444 |
2,541 |
2,583 |
2,528 |
2,721 |
2,412 |
2,434 |
2,334 |
2,184 |
2,200 |
| Total Non-Interest Expense |
|
1,745 |
1,942 |
2,097 |
2,215 |
2,306 |
3,514 |
1,834 |
1,687 |
1,678 |
1,614 |
1,619 |
| Property & Liability Insurance Claims |
|
980 |
1,166 |
1,310 |
1,374 |
1,484 |
2,744 |
1,042 |
879 |
951 |
984 |
942 |
| Other Operating Expenses |
|
36 |
39 |
35 |
26 |
-13 |
23 |
24 |
23 |
12 |
19 |
19 |
| Amortization Expense |
|
594 |
631 |
644 |
690 |
678 |
647 |
643 |
660 |
601 |
522 |
563 |
| Other Special Charges |
|
134 |
106 |
108 |
125 |
157 |
100 |
126 |
125 |
113 |
89 |
95 |
| Income Tax Expense |
|
-554 |
15 |
-21 |
102 |
-64 |
-46 |
177 |
149 |
116 |
33 |
139 |
| Preferred Stock Dividends Declared |
|
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
8.84 |
| Net Income / (Loss) Attributable to Noncontrolling Interest |
|
403 |
245 |
225 |
450 |
170 |
-195 |
328 |
415 |
387 |
222 |
315 |
| Basic Earnings per Share |
|
$31.54 |
$6.96 |
$9.44 |
$22.68 |
($3.77) |
$3.29 |
$17.25 |
$19.47 |
$16.22 |
$6.60 |
$15.54 |
| Weighted Average Basic Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
| Weighted Average Diluted Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
Annual Cash Flow Statements for RenaissanceRe
This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
-19 |
-86 |
940 |
-254 |
271 |
358 |
122 |
-665 |
683 |
-201 |
55 |
| Net Cash From Operating Activities |
|
425 |
485 |
1,026 |
1,222 |
2,137 |
1,993 |
1,235 |
1,604 |
1,912 |
4,165 |
3,693 |
| Net Cash From Continuing Operating Activities |
|
512 |
322 |
1,026 |
1,222 |
2,137 |
1,993 |
1,235 |
1,604 |
1,912 |
4,165 |
3,693 |
| Net Income / (Loss) Continuing Operations |
|
542 |
630 |
-355 |
269 |
950 |
993 |
-103 |
-1,160 |
3,620 |
2,961 |
3,618 |
| Consolidated Net Income / (Loss) |
|
542 |
630 |
-355 |
269 |
950 |
993 |
-103 |
-1,160 |
3,620 |
2,961 |
3,618 |
| Depreciation Expense |
|
18 |
29 |
31 |
0.12 |
-59 |
17 |
-21 |
-27 |
-135 |
258 |
-14 |
| Non-Cash Adjustments to Reconcile Net Income |
|
73 |
-147 |
-154 |
230 |
-415 |
-789 |
219 |
1,646 |
-490 |
-20 |
-1,199 |
| Changes in Operating Assets and Liabilities, net |
|
-208 |
-27 |
1,503 |
723 |
1,661 |
1,772 |
1,140 |
1,145 |
-1,083 |
966 |
1,289 |
| Net Cash From Investing Activities |
|
-339 |
-165 |
-122 |
-2,537 |
-2,989 |
-2,305 |
-816 |
-3,016 |
-3,823 |
-3,061 |
-2,216 |
| Net Cash From Continuing Investing Activities |
|
-339 |
-165 |
-122 |
-2,537 |
-2,989 |
-2,305 |
-816 |
-3,016 |
-3,823 |
-3,061 |
-2,216 |
| Purchase of Investment Securities |
|
-10,519 |
-8,470 |
-10,113 |
-14,147 |
-20,306 |
-17,638 |
-16,575 |
-52,789 |
-67,833 |
-59,398 |
-61,476 |
| Sale and/or Maturity of Investments |
|
10,180 |
8,121 |
9,875 |
11,611 |
17,325 |
15,196 |
15,552 |
49,773 |
64,011 |
56,337 |
59,260 |
| Net Cash From Financing Activities |
|
-94 |
-401 |
29 |
1,066 |
1,120 |
665 |
-302 |
725 |
2,589 |
-1,288 |
-1,411 |
| Net Cash From Continuing Financing Activities |
|
-94 |
-401 |
29 |
1,066 |
1,120 |
665 |
-302 |
725 |
2,589 |
-1,288 |
-1,411 |
| Issuance of Debt |
|
446 |
0.00 |
296 |
0.00 |
396 |
0.00 |
30 |
0.00 |
816 |
75 |
964 |
| Issuance of Common Equity |
|
- |
0.00 |
0.00 |
250 |
0.00 |
1,096 |
0.00 |
0.00 |
1,352 |
0.00 |
0.00 |
| Repayment of Debt |
|
- |
0.00 |
-250 |
0.00 |
0.00 |
-250 |
0.00 |
0.00 |
-30 |
-150 |
-525 |
| Repurchase of Common Equity |
|
-260 |
-309 |
-189 |
0.00 |
0.00 |
-63 |
-1,028 |
-167 |
0.00 |
-667 |
-1,600 |
| Payment of Dividends |
|
-76 |
-74 |
-74 |
-83 |
-96 |
-99 |
-101 |
-100 |
-110 |
-116 |
-110 |
| Other Financing Activities, Net |
|
-203 |
-18 |
245 |
658 |
820 |
107 |
582 |
992 |
562 |
-429 |
-140 |
| Effect of Exchange Rate Changes |
|
-11 |
-4.64 |
8.22 |
-5.10 |
2.48 |
4.49 |
6.15 |
22 |
5.54 |
-17 |
-12 |
| Cash Interest Paid |
|
41 |
54 |
44 |
46 |
53 |
49 |
21 |
46 |
74 |
88 |
112 |
Quarterly Cash Flow Statements for RenaissanceRe
This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| Net Change in Cash & Equivalents |
|
682 |
-271 |
20 |
-54 |
104 |
-44 |
-204 |
273 |
30 |
-168 |
-261 |
| Net Cash From Operating Activities |
|
512 |
683 |
1,212 |
1,490 |
779 |
158 |
1,470 |
1,583 |
483 |
688 |
852 |
| Net Cash From Continuing Operating Activities |
|
512 |
683 |
1,212 |
1,490 |
779 |
158 |
1,470 |
1,583 |
483 |
688 |
852 |
| Net Income / (Loss) Continuing Operations |
|
1,989 |
618 |
729 |
1,633 |
-19 |
-25 |
1,164 |
1,332 |
1,148 |
516 |
978 |
| Consolidated Net Income / (Loss) |
|
1,989 |
618 |
729 |
1,633 |
-19 |
-25 |
1,164 |
1,332 |
1,148 |
516 |
978 |
| Depreciation Expense |
|
-14 |
16 |
9.96 |
226 |
6.85 |
3.74 |
5.42 |
-6.72 |
-17 |
-24 |
-23 |
| Non-Cash Adjustments to Reconcile Net Income |
|
-637 |
165 |
139 |
-843 |
519 |
-190 |
-185 |
-133 |
-691 |
420 |
-125 |
| Changes in Operating Assets and Liabilities, net |
|
-825 |
-116 |
335 |
475 |
272 |
369 |
485 |
391 |
43 |
-224 |
22 |
| Net Cash From Investing Activities |
|
-314 |
-304 |
-979 |
-1,497 |
-280 |
-499 |
-751 |
-1,050 |
85 |
471 |
-682 |
| Net Cash From Continuing Investing Activities |
|
-314 |
-304 |
-979 |
-1,497 |
-280 |
-499 |
-751 |
-1,050 |
85 |
471 |
-682 |
| Purchase of Investment Securities |
|
-22,432 |
-14,909 |
-18,292 |
-13,906 |
-12,370 |
-14,228 |
-11,984 |
-18,449 |
-16,814 |
-16,782 |
-19,474 |
| Sale and/or Maturity of Investments |
|
22,118 |
14,605 |
17,313 |
12,410 |
12,090 |
13,729 |
11,233 |
17,399 |
16,898 |
17,253 |
18,791 |
| Net Cash From Financing Activities |
|
485 |
-645 |
-209 |
-58 |
-376 |
290 |
-917 |
-261 |
-522 |
-1,318 |
-425 |
| Net Cash From Continuing Financing Activities |
|
485 |
-645 |
-209 |
-58 |
-376 |
290 |
-917 |
-261 |
-522 |
-1,318 |
-425 |
| Repurchase of Common Equity |
|
- |
0.00 |
- |
-107 |
-452 |
-358 |
-374 |
-208 |
-660 |
-352 |
-350 |
| Payment of Dividends |
|
-29 |
-29 |
-29 |
-29 |
-29 |
-28 |
-28 |
-27 |
-26 |
-26 |
-26 |
| Other Financing Activities, Net |
|
438 |
-540 |
-146 |
103 |
154 |
-190 |
-25 |
9.72 |
65 |
-940 |
-48 |
| Effect of Exchange Rate Changes |
|
-1.86 |
-5.21 |
-3.57 |
10 |
-19 |
7.50 |
-5.07 |
0.97 |
-16 |
-8.72 |
-6.20 |
Annual Balance Sheets for RenaissanceRe
This table presents RenaissanceRe's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
11,555 |
12,352 |
15,226 |
18,676 |
26,330 |
30,821 |
33,960 |
36,553 |
49,007 |
50,708 |
53,800 |
| Cash and Due from Banks |
|
507 |
421 |
1,362 |
1,108 |
1,379 |
1,737 |
1,859 |
1,194 |
1,878 |
1,677 |
1,731 |
| Trading Account Securities |
|
7,309 |
7,399 |
7,917 |
9,299 |
12,803 |
15,564 |
16,144 |
17,551 |
24,612 |
28,108 |
31,313 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Accrued Investment Income |
|
40 |
38 |
42 |
51 |
72 |
67 |
56 |
122 |
206 |
238 |
234 |
| Unearned Premiums Asset |
|
1,009 |
1,429 |
1,838 |
2,153 |
6,159 |
6,644 |
8,905 |
10,872 |
13,550 |
12,660 |
12,146 |
| Deferred Acquisition Cost |
|
199 |
335 |
427 |
477 |
664 |
634 |
849 |
1,172 |
1,751 |
1,552 |
1,539 |
| Intangible Assets |
|
265 |
251 |
243 |
237 |
262 |
250 |
243 |
238 |
775 |
704 |
633 |
| Other Assets |
|
2,226 |
2,479 |
3,398 |
5,350 |
4,991 |
5,925 |
5,903 |
5,405 |
6,235 |
5,768 |
6,204 |
| Total Liabilities & Shareholders' Equity |
|
11,555 |
12,352 |
15,226 |
18,676 |
26,330 |
30,821 |
33,960 |
36,553 |
49,007 |
50,708 |
53,800 |
| Total Liabilities |
|
5,777 |
6,310 |
9,538 |
11,579 |
17,287 |
19,872 |
23,781 |
26,692 |
33,451 |
33,156 |
34,590 |
| Short-Term Debt |
|
391 |
306 |
209 |
380 |
225 |
1,133 |
1,171 |
494 |
662 |
151 |
533 |
| Long-Term Debt |
|
960 |
949 |
990 |
991 |
1,384 |
1,136 |
1,168 |
1,170 |
1,959 |
1,887 |
2,329 |
| Claims and Claim Expense |
|
2,767 |
2,848 |
5,080 |
6,076 |
9,384 |
10,381 |
13,295 |
15,893 |
20,487 |
21,303 |
22,302 |
| Unearned Premiums Liability |
|
889 |
1,232 |
1,478 |
1,716 |
2,531 |
2,764 |
3,531 |
4,559 |
6,136 |
5,950 |
6,028 |
| Other Long-Term Liabilities |
|
769 |
976 |
1,782 |
2,416 |
3,763 |
4,458 |
4,616 |
4,576 |
4,208 |
3,864 |
3,397 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
|
1,046 |
1,176 |
1,297 |
2,052 |
3,071 |
3,388 |
3,554 |
4,535 |
6,101 |
6,978 |
7,602 |
| Total Equity & Noncontrolling Interests |
|
4,732 |
4,867 |
4,391 |
5,045 |
5,971 |
7,560 |
6,624 |
5,325 |
9,455 |
10,574 |
11,609 |
| Total Preferred & Common Equity |
|
4,732 |
4,867 |
4,391 |
5,045 |
5,971 |
7,560 |
6,624 |
5,325 |
9,455 |
10,574 |
11,609 |
| Preferred Stock |
|
400 |
400 |
400 |
650 |
650 |
525 |
750 |
750 |
750 |
750 |
750 |
| Total Common Equity |
|
4,332 |
4,467 |
3,991 |
4,395 |
5,321 |
7,035 |
5,874 |
4,575 |
8,705 |
9,824 |
10,859 |
| Common Stock |
|
551 |
258 |
77 |
338 |
612 |
1,674 |
653 |
519 |
2,197 |
1,563 |
44 |
| Retained Earnings |
|
3,779 |
4,208 |
3,914 |
4,058 |
4,711 |
5,374 |
5,233 |
4,071 |
6,522 |
8,276 |
10,827 |
| Accumulated Other Comprehensive Income / (Loss) |
|
2.11 |
1.13 |
0.22 |
-1.43 |
-1.94 |
-13 |
-11 |
-15 |
-14 |
-15 |
-13 |
Quarterly Balance Sheets for RenaissanceRe
This table presents RenaissanceRe's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q1 2026 |
Q2 2026 |
| Total Assets |
|
38,270 |
41,400 |
40,843 |
50,944 |
51,568 |
52,756 |
53,633 |
54,728 |
54,498 |
53,718 |
55,196 |
| Cash and Due from Banks |
|
1,064 |
944 |
1,196 |
1,607 |
1,627 |
1,573 |
1,633 |
1,429 |
1,702 |
1,563 |
1,302 |
| Trading Account Securities |
|
18,032 |
19,070 |
19,352 |
24,877 |
26,168 |
28,731 |
28,539 |
28,833 |
29,786 |
31,288 |
32,264 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Accrued Investment Income |
|
122 |
148 |
154 |
197 |
226 |
223 |
217 |
229 |
225 |
235 |
251 |
| Unearned Premiums Asset |
|
11,771 |
12,367 |
6,958 |
9,714 |
15,081 |
9,424 |
14,230 |
14,822 |
9,347 |
13,184 |
13,701 |
| Deferred Acquisition Cost |
|
1,242 |
1,301 |
1,267 |
1,822 |
1,816 |
1,719 |
1,685 |
1,732 |
1,656 |
1,666 |
1,706 |
| Intangible Assets |
|
237 |
235 |
234 |
759 |
737 |
717 |
686 |
669 |
651 |
618 |
602 |
| Other Assets |
|
5,802 |
7,242 |
11,683 |
11,968 |
5,913 |
10,369 |
6,644 |
7,014 |
11,131 |
5,166 |
5,370 |
| Total Liabilities & Shareholders' Equity |
|
38,270 |
41,400 |
40,843 |
50,944 |
51,568 |
52,756 |
53,633 |
54,728 |
54,498 |
53,718 |
55,196 |
| Total Liabilities |
|
27,047 |
28,321 |
27,592 |
34,854 |
35,053 |
34,653 |
36,595 |
36,885 |
35,527 |
35,161 |
36,032 |
| Short-Term Debt |
|
389 |
548 |
812 |
1,428 |
778 |
607 |
552 |
492 |
299 |
309 |
550 |
| Long-Term Debt |
|
1,141 |
1,882 |
1,883 |
1,884 |
1,960 |
1,936 |
2,754 |
2,263 |
2,229 |
2,330 |
2,331 |
| Claims and Claim Expense |
|
15,997 |
16,138 |
15,955 |
20,370 |
20,741 |
21,221 |
22,857 |
22,914 |
22,713 |
22,291 |
22,269 |
| Unearned Premiums Liability |
|
5,251 |
5,717 |
5,222 |
7,248 |
7,697 |
7,041 |
6,999 |
7,561 |
6,987 |
6,885 |
7,176 |
| Other Long-Term Liabilities |
|
4,270 |
4,035 |
3,720 |
3,924 |
3,877 |
3,848 |
3,433 |
3,654 |
3,299 |
3,346 |
3,706 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
|
5,357 |
5,676 |
5,662 |
6,298 |
6,335 |
6,861 |
6,690 |
7,043 |
7,469 |
7,043 |
7,343 |
| Total Equity & Noncontrolling Interests |
|
5,866 |
7,403 |
7,589 |
9,793 |
10,179 |
11,243 |
10,349 |
10,800 |
11,502 |
11,514 |
11,820 |
| Total Preferred & Common Equity |
|
5,866 |
7,403 |
7,589 |
9,793 |
10,179 |
11,243 |
10,349 |
10,800 |
11,502 |
11,514 |
11,820 |
| Preferred Stock |
|
750 |
750 |
750 |
750 |
750 |
750 |
750 |
750 |
750 |
750 |
750 |
| Total Common Equity |
|
5,116 |
6,653 |
6,839 |
9,043 |
9,429 |
10,493 |
9,599 |
10,050 |
10,752 |
10,764 |
11,070 |
| Common Stock |
|
512 |
1,876 |
1,888 |
2,190 |
2,101 |
2,011 |
1,196 |
838 |
652 |
43 |
42 |
| Retained Earnings |
|
4,619 |
4,790 |
4,965 |
6,866 |
7,341 |
8,495 |
8,418 |
9,225 |
10,114 |
10,733 |
11,041 |
| Accumulated Other Comprehensive Income / (Loss) |
|
-15 |
-14 |
-15 |
-14 |
-13 |
-13 |
-15 |
-14 |
-14 |
-12 |
-13 |
Annual Metrics And Ratios for RenaissanceRe
This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
46,109,518.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
46,109,518.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
78.46 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$9.36 |
$11.50 |
($6.15) |
$4.91 |
$16.32 |
$15.34 |
($1.57) |
($25.50) |
$52.40 |
$35.31 |
$56.23 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
43.14M |
40.94M |
40.02M |
42.21M |
44.15M |
50.71M |
43.98M |
43.72M |
52.69M |
49.25M |
43.49M |
| Adjusted Diluted Earnings per Share |
|
$9.28 |
$11.43 |
($6.15) |
$4.91 |
$16.29 |
$15.31 |
($1.57) |
($25.50) |
$52.27 |
$35.21 |
$56.03 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
43.14M |
40.94M |
40.02M |
42.21M |
44.15M |
50.71M |
43.98M |
43.72M |
52.69M |
49.25M |
43.49M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
43.14M |
40.94M |
40.02M |
42.21M |
44.15M |
50.71M |
43.98M |
43.72M |
52.69M |
49.25M |
43.49M |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Quarterly Metrics And Ratios for RenaissanceRe
This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
46,109,518.00 |
43,488,908.00 |
42,633,041.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
46,109,518.00 |
43,488,908.00 |
42,633,041.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
24.89 |
11.86 |
22.95 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
57.53% |
17.48% |
52.63% |
116.44% |
-30.09% |
33.66% |
13.19% |
-19.81% |
- |
-37.18% |
-13.80% |
| EBITDA Growth |
|
111.09% |
-22.29% |
110.83% |
418.62% |
-105.37% |
-110.32% |
87.53% |
-24.81% |
- |
882.17% |
-18.68% |
| EBIT Growth |
|
105.27% |
-27.08% |
85.90% |
307.37% |
-105.80% |
-111.17% |
89.41% |
-14.65% |
- |
875.31% |
-16.62% |
| NOPAT Growth |
|
186.81% |
-26.40% |
94.42% |
291.97% |
-102.93% |
-108.01% |
59.71% |
-18.43% |
- |
1,141.03% |
-15.93% |
| Net Income Growth |
|
186.81% |
-26.40% |
94.42% |
291.97% |
-100.97% |
-104.08% |
59.71% |
-18.43% |
- |
2,142.00% |
-15.93% |
| EPS Growth |
|
202.60% |
-46.24% |
130.07% |
495.26% |
-111.95% |
-52.88% |
82.78% |
-14.24% |
- |
100.92% |
0.00% |
| Operating Cash Flow Growth |
|
-30.10% |
56.86% |
534.83% |
92.91% |
51.99% |
-76.92% |
21.22% |
6.22% |
- |
335.80% |
-42.00% |
| Free Cash Flow Firm Growth |
|
-376.60% |
-2,565.38% |
10.16% |
34.89% |
68.44% |
83.57% |
93.97% |
115.59% |
- |
66.09% |
-157.57% |
| Invested Capital Growth |
|
57.71% |
52.14% |
24.14% |
29.48% |
7.77% |
4.85% |
6.99% |
4.13% |
- |
4.19% |
7.02% |
| Revenue Q/Q Growth |
|
73.16% |
-19.55% |
9.79% |
40.49% |
-44.06% |
54.92% |
-7.80% |
-0.23% |
- |
-26.46% |
26.52% |
| EBITDA Q/Q Growth |
|
275.85% |
-54.26% |
10.44% |
173.12% |
-103.89% |
12.10% |
2,107.40% |
9.50% |
- |
-57.95% |
108.70% |
| EBIT Q/Q Growth |
|
236.84% |
-55.81% |
11.66% |
145.09% |
-104.79% |
14.85% |
1,993.82% |
10.44% |
- |
-56.57% |
103.66% |
| NOPAT Q/Q Growth |
|
377.41% |
-68.90% |
17.81% |
124.08% |
-103.56% |
14.85% |
2,448.51% |
14.44% |
- |
-55.05% |
89.66% |
| Net Income Q/Q Growth |
|
377.41% |
-68.90% |
17.81% |
124.08% |
-101.18% |
-31.42% |
4,706.67% |
14.44% |
- |
-55.05% |
89.66% |
| EPS Q/Q Growth |
|
728.16% |
-77.95% |
35.59% |
140.38% |
-116.62% |
186.97% |
425.99% |
12.79% |
- |
-59.34% |
0.00% |
| Operating Cash Flow Q/Q Growth |
|
-33.65% |
33.36% |
77.38% |
22.92% |
-47.73% |
-79.74% |
831.44% |
7.71% |
- |
42.36% |
23.97% |
| Free Cash Flow Firm Q/Q Growth |
|
1.05% |
-29.35% |
50.01% |
-1.76% |
52.05% |
32.66% |
81.65% |
363.10% |
- |
74.86% |
-39.40% |
| Invested Capital Q/Q Growth |
|
13.99% |
6.75% |
-0.78% |
7.24% |
-5.12% |
3.85% |
1.25% |
4.38% |
- |
-3.97% |
4.00% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
44.69% |
25.22% |
25.37% |
49.33% |
-3.43% |
-1.95% |
42.40% |
46.53% |
- |
24.25% |
39.99% |
| EBIT Margin |
|
45.12% |
24.60% |
25.02% |
43.65% |
-3.74% |
-2.06% |
42.22% |
46.74% |
- |
25.37% |
40.84% |
| Profit (Net Income) Margin |
|
62.55% |
24.01% |
25.76% |
41.09% |
-0.86% |
-0.73% |
36.65% |
42.04% |
- |
23.85% |
35.75% |
| Tax Burden Percent |
|
138.64% |
97.57% |
102.95% |
94.12% |
23.12% |
35.69% |
86.81% |
89.95% |
- |
93.99% |
87.53% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
- |
100.00% |
100.00% |
| Effective Tax Rate |
|
-38.64% |
2.43% |
-2.95% |
5.88% |
0.00% |
0.00% |
13.19% |
10.05% |
- |
6.01% |
12.47% |
| Return on Invested Capital (ROIC) |
|
38.17% |
14.10% |
15.44% |
28.20% |
-1.61% |
-0.90% |
23.62% |
24.05% |
- |
13.14% |
18.46% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
38.17% |
14.10% |
15.44% |
28.20% |
0.06% |
-0.17% |
23.62% |
24.05% |
- |
13.14% |
18.46% |
| Return on Net Nonoperating Assets (RNNOA) |
|
6.43% |
2.50% |
2.70% |
4.71% |
0.01% |
-0.03% |
3.78% |
3.29% |
- |
2.19% |
2.81% |
| Return on Equity (ROE) |
|
44.60% |
16.60% |
18.14% |
32.91% |
-1.60% |
-0.94% |
27.39% |
27.34% |
- |
15.34% |
21.27% |
| Cash Return on Invested Capital (CROIC) |
|
-20.41% |
-20.22% |
0.05% |
1.46% |
8.19% |
6.92% |
7.06% |
7.58% |
- |
15.92% |
11.85% |
| Operating Return on Assets (OROA) |
|
9.56% |
5.21% |
5.61% |
11.71% |
-0.87% |
-0.49% |
10.20% |
10.51% |
- |
5.41% |
8.18% |
| Return on Assets (ROA) |
|
13.25% |
5.08% |
5.77% |
11.02% |
-0.20% |
-0.17% |
8.85% |
9.45% |
- |
5.09% |
7.16% |
| Return on Common Equity (ROCE) |
|
23.30% |
8.61% |
9.86% |
18.19% |
-0.90% |
-0.53% |
15.53% |
15.67% |
- |
8.77% |
12.14% |
| Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
34.70% |
36.86% |
44.19% |
0.00% |
22.39% |
25.48% |
21.31% |
- |
36.12% |
33.62% |
| Net Operating Profit after Tax (NOPAT) |
|
1,989 |
618 |
729 |
1,633 |
-58 |
-50 |
1,164 |
1,332 |
- |
516 |
978 |
| NOPAT Margin |
|
62.55% |
24.01% |
25.76% |
41.09% |
-2.62% |
-1.44% |
36.65% |
42.04% |
- |
23.85% |
35.75% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-1.67% |
-0.73% |
0.00% |
0.00% |
- |
0.00% |
0.00% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
0.00% |
| Operating Expenses to Revenue |
|
54.88% |
75.40% |
74.98% |
56.35% |
103.74% |
102.06% |
57.78% |
53.26% |
- |
74.63% |
59.16% |
| Earnings before Interest and Taxes (EBIT) |
|
1,434 |
634 |
708 |
1,735 |
-83 |
-71 |
1,341 |
1,481 |
- |
549 |
1,118 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
1,421 |
650 |
718 |
1,960 |
-76 |
-67 |
1,346 |
1,474 |
- |
524 |
1,095 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
1.14 |
1.33 |
1.25 |
1.35 |
1.32 |
1.23 |
1.18 |
1.11 |
- |
1.20 |
1.22 |
| Price to Tangible Book Value (P/TBV) |
|
1.26 |
1.45 |
1.36 |
1.45 |
1.42 |
1.33 |
1.26 |
1.18 |
- |
1.27 |
1.29 |
| Price to Revenue (P/Rev) |
|
1.10 |
1.27 |
1.13 |
1.13 |
1.11 |
0.95 |
0.92 |
0.99 |
- |
1.13 |
1.23 |
| Price to Earnings (P/E) |
|
3.95 |
5.16 |
4.49 |
3.94 |
7.04 |
7.25 |
6.02 |
7.04 |
- |
4.67 |
5.20 |
| Dividend Yield |
|
0.78% |
0.65% |
0.69% |
0.57% |
0.63% |
0.65% |
0.65% |
0.63% |
- |
0.54% |
0.51% |
| Earnings Yield |
|
25.34% |
19.38% |
22.26% |
25.41% |
14.20% |
13.80% |
16.61% |
14.20% |
- |
21.43% |
19.23% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.97 |
1.07 |
1.04 |
1.10 |
1.07 |
1.03 |
1.02 |
0.98 |
- |
1.03 |
1.05 |
| Enterprise Value to Revenue (EV/Rev) |
|
1.94 |
2.20 |
1.92 |
1.81 |
1.81 |
1.68 |
1.63 |
1.74 |
- |
1.90 |
2.11 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
5.90 |
7.44 |
6.32 |
4.80 |
6.46 |
8.26 |
6.62 |
7.85 |
- |
4.75 |
5.34 |
| Enterprise Value to EBIT (EV/EBIT) |
|
5.65 |
7.22 |
6.25 |
5.05 |
7.02 |
9.15 |
7.17 |
7.87 |
- |
4.70 |
5.26 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
4.85 |
6.11 |
5.33 |
4.59 |
7.10 |
9.04 |
7.61 |
8.57 |
- |
5.24 |
5.83 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
9.19 |
9.61 |
6.29 |
5.85 |
5.05 |
5.75 |
5.37 |
5.26 |
- |
5.16 |
6.43 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
2,337.74 |
85.19 |
13.58 |
15.22 |
14.89 |
13.14 |
- |
6.59 |
9.17 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.17 |
0.21 |
0.17 |
0.14 |
0.12 |
0.19 |
0.15 |
0.13 |
- |
0.14 |
0.15 |
| Long-Term Debt to Equity |
|
0.13 |
0.12 |
0.12 |
0.11 |
0.11 |
0.16 |
0.13 |
0.12 |
- |
0.13 |
0.12 |
| Financial Leverage |
|
0.17 |
0.18 |
0.17 |
0.17 |
0.14 |
0.20 |
0.16 |
0.14 |
- |
0.17 |
0.15 |
| Leverage Ratio |
|
3.37 |
3.27 |
3.14 |
2.99 |
3.01 |
3.16 |
3.09 |
2.89 |
- |
3.02 |
2.97 |
| Compound Leverage Factor |
|
3.37 |
3.27 |
3.14 |
2.99 |
3.01 |
3.16 |
3.09 |
2.89 |
- |
3.02 |
2.97 |
| Debt to Total Capital |
|
14.42% |
17.07% |
14.22% |
12.31% |
10.40% |
16.25% |
13.38% |
11.76% |
- |
12.45% |
13.07% |
| Short-Term Debt to Total Capital |
|
3.64% |
7.36% |
4.04% |
2.94% |
0.77% |
2.71% |
2.39% |
1.39% |
- |
1.46% |
2.50% |
| Long-Term Debt to Total Capital |
|
10.78% |
9.71% |
10.18% |
9.38% |
9.63% |
13.54% |
10.99% |
10.37% |
- |
10.99% |
10.57% |
| Preferred Equity to Total Capital |
|
4.13% |
3.87% |
3.90% |
3.63% |
3.83% |
3.69% |
3.64% |
3.49% |
- |
3.54% |
3.40% |
| Noncontrolling Interests to Total Capital |
|
33.57% |
32.46% |
32.91% |
33.23% |
35.62% |
32.88% |
34.19% |
34.74% |
- |
33.23% |
33.31% |
| Common Equity to Total Capital |
|
47.89% |
46.60% |
48.97% |
50.82% |
50.15% |
47.18% |
48.79% |
50.01% |
- |
50.78% |
50.22% |
| Debt to EBITDA |
|
0.88 |
1.19 |
0.86 |
0.54 |
0.63 |
1.30 |
0.87 |
0.94 |
- |
0.57 |
0.66 |
| Net Debt to EBITDA |
|
0.25 |
0.61 |
0.35 |
0.20 |
0.11 |
0.66 |
0.42 |
0.31 |
- |
0.23 |
0.36 |
| Long-Term Debt to EBITDA |
|
0.66 |
0.68 |
0.62 |
0.41 |
0.58 |
1.09 |
0.72 |
0.83 |
- |
0.51 |
0.54 |
| Debt to NOPAT |
|
0.72 |
0.97 |
0.73 |
0.51 |
0.69 |
1.43 |
1.00 |
1.03 |
- |
0.63 |
0.73 |
| Net Debt to NOPAT |
|
0.21 |
0.50 |
0.30 |
0.20 |
0.12 |
0.72 |
0.48 |
0.34 |
- |
0.26 |
0.40 |
| Long-Term Debt to NOPAT |
|
0.54 |
0.55 |
0.52 |
0.39 |
0.64 |
1.19 |
0.82 |
0.91 |
- |
0.56 |
0.59 |
| Noncontrolling Interest Sharing Ratio |
|
47.75% |
48.16% |
45.66% |
44.72% |
44.03% |
43.73% |
43.31% |
42.70% |
- |
42.79% |
42.93% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
-4,663 |
-6,031 |
-3,015 |
-3,068 |
-1,471 |
-991 |
-182 |
478 |
- |
-336 |
-468 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
-76.38 |
-261.05 |
0.00 |
0.00 |
-20.82 |
-36.58 |
-5.72 |
15.64 |
- |
-10.57 |
-14.74 |
| Operating Cash Flow to Interest Expense |
|
8.40 |
29.58 |
0.00 |
0.00 |
11.02 |
5.82 |
46.22 |
51.76 |
- |
21.63 |
26.82 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
8.40 |
29.58 |
0.00 |
0.00 |
11.02 |
5.82 |
46.22 |
51.76 |
- |
21.63 |
26.82 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.21 |
0.21 |
0.22 |
0.27 |
0.23 |
0.24 |
0.24 |
0.22 |
- |
0.21 |
0.20 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
18,176 |
19,403 |
19,253 |
20,646 |
19,589 |
20,344 |
20,598 |
21,499 |
- |
21,196 |
22,045 |
| Invested Capital Turnover |
|
0.61 |
0.59 |
0.60 |
0.69 |
0.61 |
0.63 |
0.64 |
0.57 |
- |
0.55 |
0.52 |
| Increase / (Decrease) in Invested Capital |
|
6,651 |
6,650 |
3,744 |
4,701 |
1,413 |
941 |
1,346 |
853 |
- |
852 |
1,447 |
| Enterprise Value (EV) |
|
17,559 |
20,759 |
20,016 |
22,788 |
21,012 |
20,933 |
20,937 |
20,997 |
- |
21,795 |
23,183 |
| Market Capitalization |
|
9,966 |
12,006 |
11,819 |
14,207 |
12,923 |
11,820 |
11,817 |
11,952 |
- |
12,926 |
13,510 |
| Book Value per Share |
|
$170.11 |
$171.01 |
$178.31 |
$201.18 |
$189.14 |
$194.89 |
$206.57 |
$228.45 |
- |
$247.52 |
$259.66 |
| Tangible Book Value per Share |
|
$154.96 |
$156.66 |
$164.36 |
$187.42 |
$175.59 |
$180.96 |
$192.82 |
$214.61 |
- |
$233.31 |
$245.53 |
| Total Capital |
|
18,176 |
19,403 |
19,253 |
20,646 |
19,589 |
20,344 |
20,598 |
21,499 |
- |
21,196 |
22,045 |
| Total Debt |
|
2,620 |
3,312 |
2,739 |
2,543 |
2,037 |
3,306 |
2,755 |
2,528 |
- |
2,639 |
2,881 |
| Total Long-Term Debt |
|
1,959 |
1,884 |
1,960 |
1,936 |
1,887 |
2,754 |
2,263 |
2,229 |
- |
2,330 |
2,331 |
| Net Debt |
|
743 |
1,706 |
1,111 |
970 |
361 |
1,673 |
1,327 |
826 |
- |
1,076 |
1,579 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
| Net Nonoperating Expense (NNE) |
|
0.00 |
0.00 |
0.00 |
0.00 |
-39 |
-24 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
| Net Nonoperating Obligations (NNO) |
|
2,620 |
3,312 |
2,739 |
2,543 |
2,037 |
3,306 |
2,755 |
2,528 |
- |
2,639 |
2,881 |
| Total Depreciation and Amortization (D&A) |
|
-14 |
16 |
9.96 |
226 |
6.85 |
3.74 |
5.42 |
-6.72 |
- |
-24 |
-23 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$31.54 |
$6.96 |
$9.44 |
$22.68 |
($3.77) |
$3.29 |
$17.25 |
$19.47 |
$16.22 |
$6.60 |
$15.54 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
| Adjusted Diluted Earnings per Share |
|
$31.47 |
$6.94 |
$9.41 |
$22.62 |
($3.76) |
$3.27 |
$17.20 |
$19.40 |
$16.16 |
$6.57 |
$0.00 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
52.69M |
52.88M |
52.16M |
51.94M |
49.25M |
48.65M |
47.07M |
46.11M |
43.49M |
42.63M |
41.55M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
1,098 |
722 |
571 |
1,751 |
52 |
21 |
1,273 |
1,444 |
- |
600 |
1,061 |
| Normalized NOPAT Margin |
|
34.54% |
28.03% |
20.19% |
44.05% |
2.33% |
0.60% |
40.09% |
45.59% |
- |
27.72% |
38.78% |
| Pre Tax Income Margin |
|
45.12% |
24.60% |
25.02% |
43.65% |
-3.74% |
-2.06% |
42.22% |
46.74% |
- |
25.37% |
40.84% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
23.50 |
27.43 |
0.00 |
0.00 |
-1.18 |
-2.61 |
42.17 |
48.41 |
- |
17.27 |
35.17 |
| NOPAT to Interest Expense |
|
32.57 |
26.77 |
0.00 |
0.00 |
-0.82 |
-1.83 |
36.60 |
43.55 |
- |
16.23 |
30.79 |
| EBIT Less CapEx to Interest Expense |
|
23.50 |
27.43 |
0.00 |
0.00 |
-1.18 |
-2.61 |
42.17 |
48.41 |
- |
17.27 |
35.17 |
| NOPAT Less CapEx to Interest Expense |
|
32.57 |
26.77 |
0.00 |
0.00 |
-0.82 |
-1.83 |
36.60 |
43.55 |
- |
16.23 |
30.79 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
3.05% |
3.36% |
3.08% |
2.34% |
3.93% |
4.97% |
4.14% |
4.59% |
- |
2.60% |
2.67% |
| Augmented Payout Ratio |
|
3.05% |
3.36% |
5.97% |
6.67% |
26.45% |
49.20% |
51.01% |
61.36% |
- |
40.93% |
42.20% |
Key Financial Trends
RenaissanceRe’s Q2 2026 results show a sharp sequential recovery, although year-over-year profitability remains below the unusually strong levels reported in 2025. Net income attributable to common shareholders increased to $654.2 million from $284.5 million in Q1 2026, while basic earnings per share rose to $15.54 from $6.60. The improvement was driven largely by $564.6 million of investment gains, compared with just $10.1 million in Q1.
Compared with Q2 2025, however, common net income declined 20.8% from $826.5 million, and basic EPS fell 9.9% from $17.25. Total revenue decreased 13.8% to $2.74 billion. Premiums earned were relatively resilient at $2.20 billion, down 8.8% year over year, but investment gains declined 28.7% from the prior-year quarter.
- Strong sequential earnings recovery: Common net income more than doubled from Q1 2026, and EPS increased to $15.54, indicating considerably better profitability in the latest quarter.
- Premium revenue remains substantial: Premiums earned were $2.20 billion in Q2 2026 and have generally remained above $2 billion per quarter since 2023, supporting a sizable recurring insurance revenue base.
- Claims expense improved year over year: Property and liability insurance claims fell to $942.4 million from $1.04 billion in Q2 2025 and $984.0 million in Q1 2026. This helped offset weaker investment income.
- Operating cash flow remains consistently positive: RenaissanceRe generated $852.4 million of operating cash flow in Q2 2026, following $687.6 million in Q1. Operating cash flow has remained positive in every reported quarter in the supplied period, even when net income was negative.
- Capital returns are reducing the share base: The company repurchased $350.5 million of common stock in Q2 2026. Weighted-average shares have declined from 52.2 million in Q2 2024 to 41.6 million in Q2 2026, which can support per-share earnings over time.
- Capital and asset base have expanded: Total assets increased to $55.2 billion from $51.6 billion in Q2 2024, while total common equity rose to $11.1 billion from $9.4 billion over the same period.
- Investment portfolio activity is very large: The company purchased $19.5 billion of investment securities and sold or received maturities of $18.8 billion in Q2 2026. This reflects active portfolio management, but investment results will remain sensitive to market conditions and interest rates.
- Cash balances are fluctuating: Cash and equivalents fell to $1.30 billion at June 30, 2026, from $1.56 billion at March 31 and $1.43 billion at June 30, 2025. The balance remains meaningful, but cash has declined as the company funded investments and shareholder returns.
- Year-over-year earnings momentum weakened: Total revenue, investment gains, pretax income and common net income were all below Q2 2025 levels. The comparison is also affected by the strong investment gains recorded in the prior-year quarter.
- Financing and investment outflows exceeded operating cash flow: Q2 2026 ended with a $260.7 million decline in cash, as $682.3 million of investing outflows and $424.5 million of financing outflows outweighed $852.4 million of operating cash generation.
Balance-sheet trends are mixed but broadly stable. Total liabilities increased to $36.0 billion from $35.2 billion in Q1 2026 and $35.1 billion in Q2 2025. Short-term debt rose sharply to $550.4 million from $308.6 million in the prior quarter, while long-term debt remained largely unchanged at $2.33 billion. Claims and claim expense reserves were $22.3 billion, slightly below the Q2 2025 level but still representing the company’s largest liability category.
Investors should also account for RenaissanceRe’s significant noncontrolling interests. Q2 2026 consolidated net income was $978.3 million, but $315.3 million was attributable to noncontrolling interests and $8.8 million to preferred dividends, leaving $654.2 million for common shareholders. Overall, the statements point to a financially productive insurer with strong operating cash generation and aggressive capital returns, but with earnings that remain exposed to investment-market volatility and quarter-to-quarter catastrophe and claims trends.
09/10/26 02:24 PM ETAI Generated. May Contain Errors.